|
CY2020025I1
(en)
|
|
BETA-LACTAMASE INHIBITORS
|
|
DK2027096T3
(en)
|
|
Substituted arylimidazolones and triazolones as inhibitors of the vasopressin receptors
|
|
EP2004654A4
(en)
|
|
ANTAGONISTS OF KINASE
|
|
ATE526325T1
(en)
|
|
SUBSTITUTED BENZIMIDAZOLES AS KINASE INHIBITORS
|
|
RU2458924C3
(en)
|
|
CONNECTIONS OF SUBSTITUTED DIAZEPANES AS ANTAGONISTS OF OREXIN RECEPTORS
|
|
HRP20151108T1
(en)
|
|
NOGO-RECEPTOR ANTAGONISTS
|
|
EP2083864A4
(en)
|
|
ANTAGONISTS OF PCSK9
|
|
EP2083859A4
(en)
|
|
ANTAGONISTS OF PCSK9
|
|
EP2083860A4
(en)
|
|
ANTAGONISTS OF PCSK9
|
|
EP2192838A4
(en)
|
|
HETEROCYCLIC INHIBITORS OF NECROPTOSIS
|
|
ATE481405T1
(en)
|
|
THIAZOLPYRAZOLOPYRIMIDINES AS ANTAGONISTS OF THE CRF1 RECEPTOR
|
|
EP2150115A4
(en)
|
|
RECEPTOR ANTAGONISTS OF CYCLOPROPYLPYRROLIDINE OREXINE
|
|
DK2041138T3
(en)
|
|
PYRROLTRIAZINKINASE INHIBITORS
|
|
EP2217701A4
(en)
|
|
ANTAGONISTS OF GLUCAGON
|
|
DK2024375T3
(en)
|
|
Cyclopropyl-condensed indolobenzazepine-HCV-NS5B inhibitors
|
|
DK2848610T3
(en)
|
|
Inhibitors of kinase activity
|
|
PL2340828T3
(en)
|
|
PHARMACEUTICAL COMBINATIONS OF ANGIOTENSIN RECEPTOR ANTAGONIST AND NEP INHIBITOR
|
|
ATE479434T1
(en)
|
|
DYHYDRODIAZEPINES USABLE AS PROTEIN KINASE INHIBITORS
|
|
KR101522157B9
(en)
|
|
Dosage of CMT inhibitors
|
|
BRPI0817835A2
(en)
|
|
CGRP ANTAGONISTS
|
|
EP2023920A4
(en)
|
|
ANTAGONISTS / INVERSE AGONISTS OF CANNABINOID RECEPTORS
|
|
BRPI0720547A2
(en)
|
|
HETEROCYCLIC DERIVED METALOPROTEASE INHIBITORS
|
|
EP2365749A4
(en)
|
|
QUINOLONE ANTAGONISTS OF THE NEUROPEPTIDE S RECEPTOR
|
|
ATE537149T1
(en)
|
|
SULFONYL-PYRAZOLINYL-1-CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS
|
|
ATE555785T1
(en)
|
|
TRIAZOLE DERIVATIVES AS SMO ANTAGONISTS
|